Evrim Resources EBIT margin
Cos'è EBIT margin di Evrim Resources?
EBIT margin di Evrim Resources Corp. è -254,529.87%
Qual è la definizione di EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin di aziende nel Materials settore su OTC rispetto a Evrim Resources
Cosa fa Evrim Resources?
Orogen Royalties Inc. operates as a mineral exploration company. It primarily explores for gold, copper, silver, and precious and base metal deposits. The company was formerly known as Evrim Resources Corp. and changed its name to Orogen Royalties Inc. in August 2020. Orogen Royalties Inc. was incorporated in 2005 and is headquartered in Vancouver, Canada.
Aziende con ebit margin simili a Evrim Resources
- Lydian International ha EBIT margin di -385,851.81%
- Clime Investment Management ha EBIT margin di -332,352.17%
- Concert Pharmaceuticals Inc ha EBIT margin di -300,735.71%
- Transgene Biotek ha EBIT margin di -299,390.78%
- Oragenics Inc ha EBIT margin di -260,928.85%
- Mydecine Innovations ha EBIT margin di -258,137.62%
- Evrim Resources ha EBIT margin di -254,529.87%
- Kazia Therapeutics ha EBIT margin di -248,657.02%
- Tocagen ha EBIT margin di -194,211.11%
- Armada Metals Ltd ha EBIT margin di -192,107.65%
- Nemaura Medical Inc ha EBIT margin di -178,352.64%
- Trillium Therapeutics Inc ha EBIT margin di -161,183.72%
- Titan Pharmaceuticals, (de) ha EBIT margin di -135,800.00%